Cue Biopharma - Stock Price History | CUE

Historical daily share price chart and data for Cue Biopharma since 2021 adjusted for splits. The latest closing stock price for Cue Biopharma as of September 24, 2021 is 14.50.
  • The all-time high Cue Biopharma stock closing price was 30.73 on June 02, 2020.
  • The Cue Biopharma 52-week high stock price is 17.23, which is 18.8% above the current share price.
  • The Cue Biopharma 52-week low stock price is 9.65, which is 33.4% below the current share price.
  • The average Cue Biopharma stock price for the last 52 weeks is 12.88.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Cue Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 18.2012 16.3100 30.7300 9.8500 12.5100 -21.20%
2019 8.2995 5.1600 17.4700 4.7000 15.8750 237.77%
2018 11.0071 11.6300 17.2500 4.3500 4.7000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.470B $0.003B
Cue Biopharma, Inc. is an immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. Cue Biopharma, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71